1. Home
  2. SHMD vs STIM Comparison

SHMD vs STIM Comparison

Compare SHMD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$4.15

Market Cap

198.2M

Sector

N/A

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.75

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHMD
STIM
Founded
1864
2003
Country
Germany
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
120.4M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
SHMD
STIM
Price
$4.15
$2.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $3.00
AVG Volume (30 Days)
491.8K
★ 1.2M
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.25
EPS
★ N/A
N/A
Revenue
N/A
★ $52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$0.80
52 Week High
$10.65
$3.44

Technical Indicators

Market Signals
Indicator
SHMD
STIM
Relative Strength Index (RSI) 61.20 46.72
Support Level $3.82 $2.65
Resistance Level $7.36 $3.25
Average True Range (ATR) 0.35 0.19
MACD 0.14 -0.04
Stochastic Oscillator 63.37 19.35

Price Performance

Historical Comparison
SHMD
STIM

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: